MX369474B - Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad. - Google Patents

Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad.

Info

Publication number
MX369474B
MX369474B MX2016011667A MX2016011667A MX369474B MX 369474 B MX369474 B MX 369474B MX 2016011667 A MX2016011667 A MX 2016011667A MX 2016011667 A MX2016011667 A MX 2016011667A MX 369474 B MX369474 B MX 369474B
Authority
MX
Mexico
Prior art keywords
extract
coriolus versicolor
autoimmunity
enhancement
topical compositions
Prior art date
Application number
MX2016011667A
Other languages
English (en)
Other versions
MX2016011667A (es
Inventor
Losa Dominguez Fernando
PALACIOS Santiago
Gaslain Yann
Original Assignee
Procare Health Iberia S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50287915&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX369474(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procare Health Iberia S L filed Critical Procare Health Iberia S L
Publication of MX2016011667A publication Critical patent/MX2016011667A/es
Publication of MX369474B publication Critical patent/MX369474B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a una composición tópica que comprende un extracto de Coriolus versicolor para su uso en la prevención y/o el tratamiento mediante administración vaginal o cervical de un trastorno vaginal y/o cervical que es causado por un agente infeccioso, en particular infecciones por el virus del papiloma humano y trastornos relacionados, incluyendo el cáncer cervical. La composición de la invención actúa potenciando la inmunidad genital frente a agentes infecciosos y reepitelizando el tejido dañado.
MX2016011667A 2014-03-13 2015-03-13 Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad. MX369474B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14159640 2014-03-13
PCT/EP2015/055349 WO2015136096A1 (en) 2014-03-13 2015-03-13 Topical compositions comprising extract of coriolus versicolor for autoimmunity enhancement

Publications (2)

Publication Number Publication Date
MX2016011667A MX2016011667A (es) 2017-02-08
MX369474B true MX369474B (es) 2019-11-08

Family

ID=50287915

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016011667A MX369474B (es) 2014-03-13 2015-03-13 Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad.

Country Status (16)

Country Link
US (2) US10874702B2 (es)
EP (1) EP3116519B1 (es)
AU (1) AU2015228775B2 (es)
CA (1) CA2940273C (es)
CL (1) CL2016002276A1 (es)
DK (1) DK3116519T3 (es)
ES (1) ES2738377T3 (es)
HR (1) HRP20191355T1 (es)
HU (1) HUE044472T2 (es)
LT (1) LT3116519T (es)
MX (1) MX369474B (es)
PL (1) PL3116519T3 (es)
PT (1) PT3116519T (es)
SI (1) SI3116519T1 (es)
TR (1) TR201911232T4 (es)
WO (1) WO2015136096A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6443278B2 (ja) * 2015-09-10 2018-12-26 豊田合成株式会社 ステアリングホイール
US11045519B2 (en) * 2017-01-31 2021-06-29 Unm Rainforest Innovations Arginine-rich polypeptide compositions and methods of using same
DE102017121066A1 (de) * 2017-08-07 2019-02-07 Boris Vestweber Zusammensetzung, insbesondere zur Pflege des Intim- oder Vaginalbereichs
CN110013465A (zh) * 2018-01-09 2019-07-16 宿迁市第一人民医院 一种和厚朴酚脂质体及其制备方法和应用
CN110101655A (zh) * 2019-05-31 2019-08-09 杨平芝 一种修复宫颈及预防细菌性阴道炎的组合物
CN115768452A (zh) * 2020-04-28 2023-03-07 伊比利亚护理健康有限公司 用于治疗由传染性病原体引起的阴道或宫颈病症的云芝提取物
IT202000014911A1 (it) * 2020-06-22 2021-12-22 Neilos S R L Composizione per la prevenzione e il trattamento delle affezioni vaginali
CN112022800B (zh) * 2020-09-21 2023-06-09 南京北极光生物科技有限公司 一种组合物和该组合物制备的阴道凝胶及其在抗人乳头瘤病毒中的应用
IT202100004214A1 (it) * 2021-02-23 2022-08-23 Zetemia S R L Composizione farmaceutica per il trattamento di infezioni da hpv
EP4342481A1 (en) 2022-09-26 2024-03-27 Hifas da Terra SL Use of an extract of hericium erinaceus for the treatment of vaginal and cervical diseases
CN117137938B (zh) * 2023-09-08 2024-04-05 广州小蛮腰医疗器械有限公司 用于阴道损伤修复的药物组合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1067861C (zh) * 1998-09-11 2001-07-04 王扬 芦荟面制食品及其制造方法
US8765138B2 (en) * 2004-01-06 2014-07-01 Paul Edward Stamets Antiviral and antibacterial activity from medicinal mushrooms
KR20030082619A (ko) * 2002-04-17 2003-10-23 종근당건강 주식회사 면역 활성 증강용 조성물
GB2415905B (en) 2003-03-06 2007-10-03 Medical Res And Education Trus Botanical extract compositions and methods of use
KR20060097847A (ko) * 2005-03-07 2006-09-18 주식회사 코오롱 히알루론산을 포함하는 식품
HUP0500582A1 (hu) 2005-06-13 2007-08-28 Csaba Jozsef Dr Jaszberenyi Szinergetikus élettani hatású élelmiszerek, élelmiszer-adalékok és táplálék-kiegészítõk vagy takarmányadalékok
US8916541B2 (en) * 2011-01-05 2014-12-23 Better Health Publishing, Inc. Synergistic combination of honokiol and modified citrus pectin in cancer therapy
US20080124303A1 (en) * 2005-12-12 2008-05-29 Cavit Sciences, Inc Methods and compositions for treatment of viral infections
EP2026810A2 (en) * 2006-05-11 2009-02-25 Patrick T. Prendergast Compositions and methods for modulating the immune system
WO2008010241A1 (en) * 2006-07-18 2008-01-24 D.M.G. Italia Srl A liposomal complex of sodium carboxymethyl beta-glucan
BRPI0701208A2 (pt) * 2007-03-26 2008-11-11 Wilton Viana processo de obtenÇço de suplemento alimentar e produto assim obtido
US7854936B2 (en) 2008-01-14 2010-12-21 Active Organics, Inc. Anti-inflammatory hydrolysate of C. versicolor
FR2949684B1 (fr) * 2009-09-04 2011-12-16 Silab Sa Principe actif issu de candida saitoana et utilisation cosmetique pour la detoxification des cellules de la peau
CO6270030A1 (es) * 2009-10-02 2011-04-20 Pontificia Universidad Javeriana Fraccion bioactiva de petivera alliacea composicion farmaceutica que la contiene y combinacion con agentes inmunoestimulantes para el tratamiento de cancer
WO2011094579A2 (en) * 2010-01-29 2011-08-04 New Chapter Inc. Mushroom compositions and methods for making and using
JP2012075390A (ja) * 2010-10-01 2012-04-19 Kiyotoshi Oshiro 乳酸菌醗酵モズクとその製造方法
CN103298476A (zh) * 2010-10-06 2013-09-11 培力有限公司 采绒革盖菌提取物及其制备方法和用途

Also Published As

Publication number Publication date
EP3116519B1 (en) 2019-05-08
CL2016002276A1 (es) 2017-06-09
AU2015228775B2 (en) 2020-04-02
US11524039B2 (en) 2022-12-13
EP3116519A1 (en) 2017-01-18
WO2015136096A1 (en) 2015-09-17
TR201911232T4 (tr) 2019-08-21
HUE044472T2 (hu) 2019-10-28
PL3116519T3 (pl) 2019-12-31
HRP20191355T1 (hr) 2019-11-01
US10874702B2 (en) 2020-12-29
US20210085738A1 (en) 2021-03-25
CA2940273C (en) 2022-12-06
AU2015228775A1 (en) 2016-10-20
PT3116519T (pt) 2019-08-06
US20170014459A1 (en) 2017-01-19
ES2738377T3 (es) 2020-01-22
MX2016011667A (es) 2017-02-08
LT3116519T (lt) 2019-08-26
SI3116519T1 (sl) 2019-09-30
DK3116519T3 (da) 2019-08-05
CA2940273A1 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
MX2016011667A (es) Composiciones topicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad.
PH12019501443A1 (en) Benzooxazole derivatives as immunomodulators
MX2019001920A (es) Arn la terapia contra el cancer.
MX2016014634A (es) Compuestos para el tratamiento de enfermedades y trastornos oftalmicos.
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
PH12015501648B1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
CL2019000935A1 (es) Composición farmacéutica, métodos para tratamiento y usos de la misma.
MX2016002544A (es) Compuestos utiles como inmunomoduladores.
TW201613919A (en) Inhibitors of Bruton's tyrosine kinase
PH12015502773A1 (en) Methods for treating or preventing opthalmological conditions
MX2017002374A (es) Composiciones y metodos para tratar trastornos de la vision.
MX368903B (es) Compuestos terapéuticos y sus usos en el tratamiento de enfermedades proliferativas.
BR112017002637A2 (pt) métodos para tratar ou prevenir condições oftalmológicas
WO2015095735A3 (en) Vaccine compositions and uses thereof
MX2017003928A (es) Composiciones farmaceuticas de accion prolongada.
CY1119532T1 (el) (s)-πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη
MX2019009586A (es) Composiciones y metodos para tratar enfermedades asociadas con la permeabilidad del epitelio intestinal.
CL2019000625A1 (es) Combinación de agonistas de fxr.
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2019007041A (es) Metodos y composiciones para tratar la enfermedad de parkinson.
MX2017013879A (es) Composiciones que comprenden anakinra.
MX2016004961A (es) Procedimientos y composiciones para el tratamiento de infecciones por s. equi.
CL2018002930A1 (es) (+)-azasetron para uso en el tratamiento de desórdenes de oído.

Legal Events

Date Code Title Description
FG Grant or registration